CASE STUDY: TECHNOLOGY

Technology: Building a roadmap for artificial intelligence

A 3D microfluidic printing platform for complex human tissues used in the next generation of regenerative therapies. 

We partnered with Aspect’s technology and product teams to define a data strategy and AI roadmap to improve quality control and tissue design.

  • Mapping AI use cases to product and strategy roadmaps 
  • Working sessions with Radical technical advisors to identify and incorporate state of the art methods
  • Definition of machine learning problem statements to match product requirements 
  • Resource requirement planning

© 2021 Radical Ventures Investments Inc.